March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world ... the appointment of Lindsay Androski, J.D., M.B.A., as Chief Executive Officer.

Sera and purified polyclonal IgG from the immunised animals neutralised HBV infection in vitro and mediated efficient HBV/hepatitis B virus surface ... such as therapeutic antibody, siRNA or Nucleic ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment ...

Questions? Please email [email protected]. Hepatitis D exists worldwide but tends to show up more often in specific groups. The hepatitis delta virus (HDV) is transmitted primarily through ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment ...

A company that is working on advancing non-viral delivery technologies for nucleic acid therapeutics, such as mRNA, small interfering ribonucleic acid (siRNA), and antisense oligonucleotides (ASOs ...

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

Sexually transmitted infections (STIs) result in millions of cases and cost over $16 billion annually in the U.S. High asymptomatic rates and stigma hinder timely diagnosis and elimination efforts.

Medscape Medical News, July 29, 2024 Combination Therapy Looks Promising for Hepatitis D The combination of the antiviral bulevirtide (Hepcludex) plus pegylated interferon alfa-2a was superior to ...

There are five kinds of hepatitis. Each has different causes, with one commonality: Hepatitis causes your liver to get inflamed. Hepatitis disease can also sometimes be spread through sexual contact.